Peripheral Artery Disease in Regular Hemodialysis Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-13

Study Completion Date

2026-07-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Recent studies have reinforced the association between high NLR and PAD in hemodialysis patients. This highlights the need for further studies to confirm its predictive value and determine optimal cut-off thresholds tailored to local patient populations. Accordingly, the present study aims to investigate the relationship between NLR and the presence of PAD in patients undergoing regular hemodialysis. By establishing this association in a well-defined population, we hope to provide evidence that supports the use of NLR as a simple, cost-effective tool for PAD risk stratification and early intervention

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

High Neutrophil-to-Lymphocyte Ratio and Patients With Hemodialysis

NCT07070557

Hemodialysis Patient

NOT_YET_RECRUITING

Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio to Predict Carotid Intima-Media Thickness in Chronic Kidney Disease Patients

NCT05472805

Chronic Kidney Diseases Dialysis; Complications Coronary Heart Disease

COMPLETED

Studying the Relationship Between Mean Platelet Volume and Neutrophil/ Lymphocyte Ratio With Inflammation and Proteinuria in Chronic Kidney Disease

NCT03149068

Evaluation of Early Inflammatory Process in CKD

UNKNOWN

Impact of Neutrophil Lymphocyte and Monocyte Lymphocyte Ratio on Chronic Kidney Disease Patients Outcome

NCT05887960

Hemodialysis Complication

UNKNOWN

Neutrophil-to-Lymphocyte and Platelet-to-lymphocyte Ratios as a Predictor Factors for Chronic Kidney Disease Progression

NCT06670599

CKD

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Kidney Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients aged ≥18 years.
* Undergoing maintenance hemodialysis for at least 3 months (thrice weekly)
* Able to provide informed consent.
* Willing to undergo clinical and laboratory evaluations, including peripheral vascular assesment

Exclusion Criteria

* Active infection or sepsis at the time of evaluation

.\* Patients who have a sedimentation rate of more than 60 mm/hour

\*. Known autoimmune or hematologic disorders that may influence leukocyte count.
* Current use of immunosuppressive therapy, corticosteroids, or chemotherapy.5. History of malignancy.6. Patients with incomplete medical records or unable to undergo peripheral vascular assessment.

Eligible Sex

ALL

Accepts Healthy Volunteers

No